Answers are grounded in this paper and cite their sources.
Focal therapy for prostate cancer could balance undertreatment and overtreatment of localized prostate cancer for highly selected patients. Long-term oncologic outcomes are not yet available for any modality. Patients should be informed regarding currently available outcomes, the necessity of adherence to a stringent follow-up protocol, and the possible need for additional targeted therapy or future radical treatment in case of recurrence.
No takes yet. Share an insight, caveat, or question.
Hayes et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: